Evidence map›Paper›PMID 25139936›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2014

Association of cancer susceptibility variants with risk of multiple primary cancers: The population architecture using genomics and epidemiology study.

S Lani Park, Christian P Caberto, Yi Lin, Robert J Goodloe, Logan Dumitrescu, Shelly-Ann Love, Tara C Matise, Lucia A Hindorff, Jay H Fowke, Fredrick R Schumacher and 16 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Association between the SNPs of theJournal of Cancer · 2018
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 13 institutions in 1 country.

S Lani ParkDepartment of Preventive Medicine, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California. sungship@usc.edu.
Christian P CabertoEpidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii.
Yi LinPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Robert J GoodloeCenter for Human Genetics Research, Vanderbilt University, Nashville, Tennessee.
Logan DumitrescuCenter for Human Genetics Research, Vanderbilt University, Nashville, Tennessee. Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee.
Shelly-Ann LoveDepartment of Epidemiology, University of North Carolina, Chapel Hill, North Carolina.
Tara C MatiseDepartment of Statistics and Biostatistics, Rutgers University, Piscataway, New Jersey.
Lucia A HindorffDivision of Genomic Medicine, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland.
Jay H FowkeVanderbilt Epidemiology Center, Vanderbilt University, Nashville, Tennessee.
Fredrick R SchumacherDepartment of Preventive Medicine, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California.
Jennifer Beebe-DimmerSchool of Medicine, Wayne State University, Detroit, Michigan. Karmanos Cancer Institute, Detroit, Michigan.
Chu ChenPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Lifang HouDepartment of Preventative Medicine, The Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Fridtjof ThomasDepartment of Preventive Medicine, University of Tennessee Health Science Center, Memphis, Tennessee.
Ewa DeelmanUSC Information Sciences Institute, University of Southern California, Marina del Rey, California.
Ying HanDepartment of Preventive Medicine, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California.
Ulrike PetersPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Kari E NorthDepartment of Epidemiology, University of North Carolina, Chapel Hill, North Carolina. Carolina Center for Genome Sciences, University of North Carolina, Chapel Hill, California.
Gerardo HeissDepartment of Epidemiology, University of North Carolina, Chapel Hill, North Carolina.
Dana C CrawfordDepartment of Epidemiology and Biostatistics, Institute for Computational Biology, Case Western Reserve University, Cleveland, Ohio.
Christopher A HaimanDepartment of Preventive Medicine, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California.
Lynne R WilkensEpidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii.
William S BushDepartment of Epidemiology and Biostatistics, Institute for Computational Biology, Case Western Reserve University, Cleveland, Ohio.
Charles KooperbergPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Iona ChengCancer Prevention Institute of California, Fremont, California.
Loïc Le MarchandEpidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii.
Fred Hutch Cancer Center · USUniversity of Southern California · USCancer Center of Hawaii · USUniversity of North Carolina at Chapel Hill · USVanderbilt University · USCase Western Reserve University · USCancer Prevention Institute of California · USMarina Del Rey Hospital · USNational Human Genome Research Institute · USRobert H. Lurie Comprehensive Cancer Center of Northwestern UniversityRutgers, The State University of New Jersey · USUniversity of Tennessee Health Science Center · USWayne State University · US

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Marian Esvelt · 1985 to 2026
$296.4M
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORTP30CA014089 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Fumito Ito · 1985 to 2026
$181.4M
University of Hawaii Cancer Center CCSGP30CA071789 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI Xin Chen · 1996 to 2026
$56.2M
The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
Multiethnic Cohort Study of Diet and CancerR37CA054281 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI KOLONEL, LAURENCE N. · 2003 to 2012
$23.2M
VALIDATION OF A DIET HISTORY METHOD FOR EPIDEMIOLOGIC STUDIES OF CANCERP01CA033619 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI KOLONEL, LAURENCE N. · 1985 to 2010
$18.5M
Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3U01CA098758 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HENDERSON, BRIAN E · 2003 to 2010
$11.0M
Cardiovascular Epidemiology Training GrantT32HL007055 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Wayne D. Rosamond · 1986 to 2026
$10.0M
Epidemiology of putative genuine genetic variant: The Women's Health IntiativeU01HG004790 · NHGRI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI KOOPERBERG, CHARLES L · 2008 to 2012
$9.9M
A Genome-wide Association Study of Prostate Cancer in African AmericansU01CA136792 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HENDERSON, BRIAN E · 2009 to 2011
$9.4M
Genetic Epidemiology of Causal Variants Across the Life CourseU01HG004803 · NHGRI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI NORTH, KARI E. · 2008 to 2012
$9.0M
Epidemiologic Architecture for Genes Linked to Environment (EAGLE)U01HG004798 · NHGRI · VANDERBILT UNIVERSITY · PI CRAWFORD, DANA C · 2008 to 2013
$8.8M
NCATS NIH HHS UL1 TR000445NCI NIH HHS P01 CA033619NCI NIH HHS P01CA33619NCI NIH HHS P30 CA014089NCI NIH HHS P30CA014089NCI NIH HHS P30 CA015704NCI NIH HHS P30 CA071789NCI NIH HHS R01 CA054281NCI NIH HHS R01 CA63NCI NIH HHS R37 CA054281NCI NIH HHS R37CA54281NCI NIH HHS U01 CA098758NCI NIH HHS U01 CA136792NCI NIH HHS U01CA136792NCI NIH HHS U01CA98758NHGRI NIH HHS U01 HG004790NHGRI NIH HHS U01HG004790NHGRI NIH HHS U01 HG004798NHGRI NIH HHS U01HG004798NHGRI NIH HHS U01 HG004801NHGRI NIH HHS U01HG004801NHGRI NIH HHS U01 HG004802NHGRI NIH HHS U01HG004802NHGRI NIH HHS U01 HG004803NHGRI NIH HHS U01HG004803NHGRI NIH HHS U01 HG007376NHGRI NIH HHS U01 HG007419NHLBI NIH HHS T32 HL007055NIGMS NIH HHS T32 GM080178WHI NIH HHS N01 WH022110WHI NIH HHS N01WH24152,WHI NIH HHS N01WH32100-2WHI NIH HHS N01WH32105-6WHI NIH HHS N01WH32108-9WHI NIH HHS N01WH32111-13WHI NIH HHS N01WH32115WHI NIH HHS N01WH32118WHI NIH HHS N01WH32119WHI NIH HHS N01WH32122WHI NIH HHS N01WH42107-26WHI NIH HHS N01WH42129-32WHI NIH HHS N01WH44221
6 · The paper itself

Abstract

backgroundMultiple primary cancers account for approximately 16% of all incident cancers in the United States. Although genome-wide association studies (GWAS) have identified many common genetic variants associated with various cancer sites, no study has examined the association of these genetic variants with risk of multiple primary cancers (MPC).

methodsAs part of the National Human Genome Research Institute (NHGRI) Population Architecture using Genomics and Epidemiology (PAGE) study, we used data from the Multiethnic Cohort (MEC) and Women's Health Initiative (WHI). Incident MPC (IMPC) cases (n = 1,385) were defined as participants diagnosed with more than one incident cancer after cohort entry. Participants diagnosed with only one incident cancer after cohort entry with follow-up equal to or longer than IMPC cases served as controls (single-index cancer controls; n = 9,626). Fixed-effects meta-analyses of unconditional logistic regression analyses were used to evaluate the associations between 188 cancer risk variants and IMPC risk. To account for multiple comparisons, we used the false-positive report probability (FPRP) to determine statistical significance.

resultsA nicotine dependence-associated and lung cancer variant, CHRNA3 rs578776 [OR, 1.16; 95% confidence interval (CI), 1.05-1.26; P = 0.004], and two breast cancer variants, EMBP1 rs11249433 and TOX3 rs3803662 (OR, 1.16; 95% CI, 1.04-1.28; P = 0.005 and OR, 1.13; 95% CI, 1.03-1.23; P = 0.006), were significantly associated with risk of IMPC. The associations for rs578776 and rs11249433 remained (P < 0.05) after removing subjects who had lung or breast cancers, respectively (P ≤ 0.046). These associations did not show significant heterogeneity by smoking status (Pheterogeneity ≥ 0.53).

conclusionsOur study has identified rs578776 and rs11249433 as risk variants for IMPC. IMPACT: These findings may help to identify genetic regions associated with IMPC risk.

Indexed as

Disease SusceptibilityAgedEpidemiologic StudiesFemaleGenetic Predisposition to DiseaseGenome-Wide Association StudyGenomicsGenotypeHumansMaleNeoplasmsPolymorphism, Single Nucleotide

Identifiers

PMID25139936
PMCPMC4221293
OpenAlexW2144045098

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.